Patient characteristics
| Characteristic . | All patients (N = 108) . | Myeloablative (n = 54) . | Nonmyeloablative (n = 54) . |
|---|---|---|---|
| Age, y | |||
| Median (IQR) | 61 (54-67) | 61 (52-67) | 61 (55-68) |
| Range | 33-75 | 34-74 | 33-75 |
| KPS | |||
| Median (IQR) | 80 (70-90) | 80 (70-90) | 70 (60-90) |
| Range | 30-100 | 30-100 | 30-100 |
| Age/KPS risk groups, n (%) | |||
| Age <51 y, any KPS | 20 (19) | 10 (19) | 10 (19) |
| Age ≥51 y, KPS ≥70 | 65 (60) | 33 (61) | 32 (59) |
| Age ≥51 y, KPS <70 | 23 (21) | 11 (20) | 12 (22) |
| Female, n (%) | 47 (44) | 22 (41) | 25 (46) |
| Elevated LDH, n (%) | 26 (25) | 13 (25) | 13 (24) |
| Deep brain involvement, n (%) | 46 (43) | 24 (44) | 22 (41) |
| Slit lamp result, n (%) | |||
| Normal | 90 (87) | 43 (83) | 47 (90) |
| Minor RPE abnormality | 7 (7) | 3 (6) | 4 (8) |
| Decrease in vitreous cells of retinal infiltrate | 1 (1) | 1 (2) | 0 (0) |
| Recurrent or new disease | 6 (6) | 5 (10) | 1 (2) |
| CSF Cytology, n (%) | |||
| Negative | 67 (76) | 35 (80) | 32 (73) |
| Atypical or suspicious | 13 (15) | 6 (14) | 7 (16) |
| Positive | 8 (9) | 3 (7) | 5 (11) |
| Characteristic . | All patients (N = 108) . | Myeloablative (n = 54) . | Nonmyeloablative (n = 54) . |
|---|---|---|---|
| Age, y | |||
| Median (IQR) | 61 (54-67) | 61 (52-67) | 61 (55-68) |
| Range | 33-75 | 34-74 | 33-75 |
| KPS | |||
| Median (IQR) | 80 (70-90) | 80 (70-90) | 70 (60-90) |
| Range | 30-100 | 30-100 | 30-100 |
| Age/KPS risk groups, n (%) | |||
| Age <51 y, any KPS | 20 (19) | 10 (19) | 10 (19) |
| Age ≥51 y, KPS ≥70 | 65 (60) | 33 (61) | 32 (59) |
| Age ≥51 y, KPS <70 | 23 (21) | 11 (20) | 12 (22) |
| Female, n (%) | 47 (44) | 22 (41) | 25 (46) |
| Elevated LDH, n (%) | 26 (25) | 13 (25) | 13 (24) |
| Deep brain involvement, n (%) | 46 (43) | 24 (44) | 22 (41) |
| Slit lamp result, n (%) | |||
| Normal | 90 (87) | 43 (83) | 47 (90) |
| Minor RPE abnormality | 7 (7) | 3 (6) | 4 (8) |
| Decrease in vitreous cells of retinal infiltrate | 1 (1) | 1 (2) | 0 (0) |
| Recurrent or new disease | 6 (6) | 5 (10) | 1 (2) |
| CSF Cytology, n (%) | |||
| Negative | 67 (76) | 35 (80) | 32 (73) |
| Atypical or suspicious | 13 (15) | 6 (14) | 7 (16) |
| Positive | 8 (9) | 3 (7) | 5 (11) |
IQR, interquartile range; LDH, lactate dehydrogenase; RPE, retinal pigment epithelium.